Organization · Venture Studio
GRIDX
GRIDX is a venture studio based in Buenos Aires, Argentina, focused on transforming scientific research into impactful biotech startups. It operates across Latin America, leveraging local talent and biodiversity to innovate in healthcare, agriculture, and materials.
Overview
What GRIDX does
What GRIDX is
GRIDX is a venture studio based in Buenos Aires, Argentina, focused on transforming scientific research into impactful biotech startups. It operates across Latin America, leveraging local talent and biodiversity to innovate in healthcare, agriculture, and materials.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Studio
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder · Program host
- Last reviewed
- March 27, 2026
What Venture studio means
A venture studio is an organization that systematically creates new startups by generating or sourcing ideas, validating them, building early products, recruiting founders or operators, providing shared resources, and retaining meaningful equity in the companies it helps create.
Open the glossary entryOfficial channels
Find GRIDX elsewhere
Open the official website or a supported primary organization account.
Capability profile
GRIDX as a funder
Investment thesis
GRIDX focuses on building companies that define the bioeconomy by leveraging biology, digital tools, and advanced engineering, aiming to transform bioscience knowledge in Latin America into impactful startups.
Focus narrative
GRIDX invests in sectors related to healthcare, agriculture, bioindustry, and materials, emphasizing life-compatible production systems. Their investment strategy supports startups innovating in agri-food, bioindustry, human health, and deep biotech, with a strong focus on the Latin American region.
Value beyond capital
GRIDX adds value to its portfolio companies by providing hands-on support in transforming scientific research into viable startups. With a team of nearly 700 employees, they operate as a venture studio, offering resources and expertise to help startups navigate the complexities of the biotech landscape.
Terms and economics
- Typical check
- $200,000–$1,500,000
Focus and fit
- Stages
- Seed · Series A
- Regions
- Latin America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 81
Portfolio context
Notable portfolio companies include: Stämm: Focused on continuous and automated manufacturing of biologics and cell therapies. Puna Bio: Develops bioinoculants using extremophile bacteria to enhance crop yields. CASPR: Specializes in CRISPR-powered diagnostics for rapid detection of infectious diseases. Beeflow: Provides professional pollination services to improve crop yield and quality. Michroma: Creates natural ingredients using fungi to replace petrochemical food dyes. OncoPrecision: Focuses on cancer drug development using patient-derived data. Bioeutectics: Develops bio-based solvents from natural compounds. Nanogrow: Innovates in biological treatments using single-domain antibodies.
Capability profile
GRIDX as a program host
Program thesis
GRIDX focuses on building companies that will define the bioeconomy by leveraging the convergence of biology, digital tools, and advanced engineering. The organization aims to transform bioscience knowledge and talent in Latin America into startups with global impact.
Focus narrative
GRIDX invests in sectors related to healthcare, agriculture, bioindustry, and materials. Their investment thesis emphasizes the development of life-compatible production systems that align with human and planetary health. They support startups that innovate in areas such as agri-food, bioindustry, human health, and deep biotech, with a particular focus on the Latin American region.
Value and support
GRIDX offers a hands-on approach to transforming scientific ideas into startups, providing initial investments, follow-on funding, and extensive support in building companies within the bioeconomy sector.
Terms and economics
- Indicative investment
- $200,000
Format and cadence
- Typical duration
- 12 weeks
- Typical cohort
- 24 companies
- Cohorts per year
- 1
- Format
- Hybrid
Availability
- Application state
- Accepting
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- Latin America
Alumni and track record
Alumni context
Notable portfolio companies include Stämm, a biotechnology company focused on continuous and automated manufacturing of biologics and cell therapies; Puna Bio, which develops bioinoculants using extremophile bacteria to enhance crop yields; CASPR, specializing in CRISPR-powered diagnostics for rapid detection of infectious diseases; Beeflow, providing professional pollination services; Michroma, creating natural ingredients using fungi; OncoPrecision, focusing on cancer drug development; Bioeutectics, developing bio-based solvents; and Nanogrow, innovating in biological treatments.
Common questions
What to know about GRIDX
Upseed classifies GRIDX under the Venture Studio organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.